1. Home
  2. CECO vs GERN Comparison

CECO vs GERN Comparison

Compare CECO & GERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CECO
  • GERN
  • Stock Information
  • Founded
  • CECO 1966
  • GERN 1990
  • Country
  • CECO United States
  • GERN United States
  • Employees
  • CECO N/A
  • GERN N/A
  • Industry
  • CECO Pollution Control Equipment
  • GERN Biotechnology: Pharmaceutical Preparations
  • Sector
  • CECO Industrials
  • GERN Health Care
  • Exchange
  • CECO Nasdaq
  • GERN Nasdaq
  • Market Cap
  • CECO 957.2M
  • GERN 853.5M
  • IPO Year
  • CECO N/A
  • GERN 1996
  • Fundamental
  • Price
  • CECO $28.49
  • GERN $1.51
  • Analyst Decision
  • CECO Strong Buy
  • GERN Buy
  • Analyst Count
  • CECO 5
  • GERN 7
  • Target Price
  • CECO $36.00
  • GERN $4.17
  • AVG Volume (30 Days)
  • CECO 248.1K
  • GERN 10.9M
  • Earning Date
  • CECO 07-29-2025
  • GERN 08-07-2025
  • Dividend Yield
  • CECO N/A
  • GERN N/A
  • EPS Growth
  • CECO 273.86
  • GERN N/A
  • EPS
  • CECO 1.30
  • GERN N/A
  • Revenue
  • CECO $608,298,000.00
  • GERN $116,293,000.00
  • Revenue This Year
  • CECO $32.90
  • GERN $160.12
  • Revenue Next Year
  • CECO $9.01
  • GERN $55.01
  • P/E Ratio
  • CECO $21.67
  • GERN N/A
  • Revenue Growth
  • CECO 8.89
  • GERN 22264.04
  • 52 Week Low
  • CECO $17.57
  • GERN $1.17
  • 52 Week High
  • CECO $35.16
  • GERN $5.06
  • Technical
  • Relative Strength Index (RSI)
  • CECO 58.45
  • GERN 51.36
  • Support Level
  • CECO $26.78
  • GERN $1.42
  • Resistance Level
  • CECO $30.56
  • GERN $1.58
  • Average True Range (ATR)
  • CECO 1.18
  • GERN 0.10
  • MACD
  • CECO 0.05
  • GERN -0.01
  • Stochastic Oscillator
  • CECO 55.00
  • GERN 40.00

About CECO CECO Environmental Corp.

CECO Environmental Corp serves the energy, industrial, and other niche markets. The company operates through the Engineered Systems segment that serves the power generation, refinery, water/wastewater, and midstream oil and gas markets, and Industrial Process Solutions segment, which serves the broad industrial air pollution control, beverage can, fluid handling, electric vehicle production, food and beverage, semi-conductor, process filtration, pharmaceutical, petrochemical, wastewater treatment, wood manufacturing, desalination, and aquaculture markets. The majority of revenue is earned from the Engineered Systems Segment.

About GERN Geron Corporation

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.

Share on Social Networks: